Dr. David Vermess, M.D.
What this data tells you about Dr. Vermess
Dr. David Vermess is a radiation oncology in Tallahassee, FL, with 18 years in practice. Based on federal Medicare data, Dr. Vermess performed 9,921 Medicare services across 1,717 unique beneficiaries.
Between the years covered by Open Payments, Dr. Vermess received a total of $469 from 7 pharmaceutical and/or device companies across 7 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in radiation oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Vermess is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Contrast dye for imaging (iodine-based) | 7,350 | $0 | $2 |
| Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | 417 | $1 | $3 |
| Chest X-ray, 1 view | 415 | $7 | $32 |
| Injection, gadobenate dimeglumine (multihance), per ml | 392 | $1 | $5 |
| Imaging for evaluation of swallowing function | 146 | $20 | $123 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 110 | $1,180 | $3,800 |
| Piflufolastat f-18, diagnostic, 1 millicurie | 109 | $472 | $603 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 97 | $391 | $500 |
| Bone density scan (DEXA) | 89 | $37 | $182 |
| Chest X-ray, 2 views | 78 | $15 | $73 |
| CT scan of abdomen and pelvis with contrast | 60 | $226 | $1,289 |
| CT scan of chest, without contrast | 56 | $98 | $699 |
| CT scan of head/brain, without contrast | 55 | $32 | $194 |
| Ct scan of chest with contrast | 53 | $98 | $784 |
| Complete ultrasound scan of abdomen | 52 | $82 | $363 |
| Mri scan of pelvis before and after contrast | 46 | $251 | $1,672 |
| Mri scan of abdomen before and after contrast | 39 | $258 | $1,672 |
| X-ray of abdomen, 1 view | 34 | $6 | $41 |
| X-ray of knee, 1-2 views | 27 | $6 | $31 |
| Ultrasound scan of head and neck soft tissue | 27 | $69 | $342 |
| Limited ultrasound scan of abdomen | 24 | $62 | $270 |
| Ct scan of blood vessels of chest with contrast | 23 | $63 | $279 |
| X-ray of hand, minimum of 3 views | 21 | $11 | $46 |
| X-ray of thigh bone, minimum 2 views | 21 | $7 | $29 |
| X-ray of lower and sacral spine, minimum of 4 views | 18 | $34 | $146 |
| Complete ultrasound scan behind abdominal cavity | 18 | $85 | $335 |
| Foot X-ray, 3+ views | 17 | $12 | $50 |
| Technetium tc-99m oxidronate, diagnostic, per study dose, up to 30 millicuries | 17 | $56 | $96 |
| Shoulder X-ray, 2+ views | 14 | $15 | $62 |
| Nuclear medicine study of bone and/or joint whole body | 13 | $206 | $764 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 13 | $16 | $70 |
| Hip X-ray, 2-3 views | 12 | $26 | $106 |
| Nuclear medicine study of liver and bile duct system with use of drugs | 12 | $315 | $1,094 |
| Technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries | 12 | $7 | $105 |
| Injection, sincalide, 5 micrograms | 12 | $99 | $141 |
| Ct scan of upper spine without contrast | 11 | $31 | $202 |
| Ct scan of abdomen and pelvis without contrast | 11 | $119 | $837 |
Industry Payment Transparency
Open Payments through 2023 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2023)
Associated products mentioned in payments ›
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2023 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Vermess is a mixed practice specialist, with above-average Medicare volume (top 20% in FL), and low-engagement industry engagement, with 18 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Vermess experienced with contrast dye for imaging (iodine-based)?
Does Dr. Vermess receive payments from pharmaceutical companies?
How do Dr. Vermess's costs compare to other radiation oncologys in Tallahassee?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology